We have previously reported that Ets transcription factors activated by ERK pathways promote transcription of ZEB1 and ZEB2 in breast cancer cells (Sinh et al., 2017), though it is unlikely that overexpression of ZEB1 would activate ERK pathway, due to drastic reduction of cell proliferation (Figure 3a). This evidence concerns the gene ZEB1 and breast carcinoma.